Showing results (721-730 of 772) with videos related to
Sort By:
Pageof 78
International Archives of Allergy and Immunology|August 26, 2006
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patientsJ M Oldhoff, U Darsow, T Werfel, et al.Allergy|December 24, 2009
Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema riskJ M Mahachie John, H Baurecht, E Rodríguez, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2000
Identification of immunological relevant phenotypes in ENU mutagenized miceH Flaswinkel, F Alessandrini, B Rathkolb, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2016
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patientsA Wollenberg, A Oranje, M Deleuran, et al.The British Journal of Dermatology|October 17, 2015
Canakinumab in adults with steroid-refractory pyoderma gangrenosumA G A Kolios, J-T Maul, B Meier, et al.Allergy|April 9, 2005
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitisJ M Oldhoff, U Darsow, T Werfel, et al.The Journal of Allergy and Clinical Immunology|July 1, 1997
Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitisH P Zenner, C Baumgarten, G Rasp, et al.Allergy|June 19, 2007
Putative association of a TLR9 promoter polymorphism with atopic eczemaN Novak, C-F Yu, C Bussmann, et al.Allergy|May 6, 2015
Pollen-derived adenosine is a necessary cofactor for ragweed allergyM Wimmer, F Alessandrini, S Gilles, et al.Cell Death & Disease|May 20, 2011
The propeptide of yeast cathepsin D inhibits programmed necrosisD Carmona-Gutiérrez, M A Bauer, J Ring, et al.Pageof 78